Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Spannagl

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Bone Marrow Research|May 27, 2014
Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of HeterozygosityKlaus Witter, Roland Reibke, Marion Subklewe, et al.
Clinical Chemistry and Laboratory Medicine|May 1, 2018
External quality assessment schemes for glucose measurements in Germany: factors for successful participation, analytical performance and medical impactAndreas Bietenbeck, Wolf J Geilenkeuser, Frank Klawonn, et al.
American Journal of Clinical Pathology|January 23, 2010
Analysis of von Willebrand factor multimers by simultaneous high- and low-resolution vertical SDS-agarose gel electrophoresis and Cy5-labeled antibody high-sensitivity fluorescence detectionHelmut W Ott, Andrea Griesmacher, Mirjam Schnapka-Koepf, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|October 29, 2008
Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplantIngo Kaczmarek, Marcus-Andre Deutsch, Teresa Kauke, et al.
Expert Review of Hematology|July 4, 2025
Review of laboratory methods used for analysis of von Willebrand factor and for diagnosis of related diseasesJürgen Patzke, Nikolaus B Binder, Mariona Bono, et al.
Expert Review of Hematology|June 24, 2025
Von Willebrand factor is a multifaceted player in hemostasis requiring a diverse array of analytical and diagnostic approachesFrançois Depasse, Nikolaus B Binder, Mariona Bono, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 12, 2006
HLA-DR matching improves survival after heart transplantation: is it time to change allocation policies?Ingo Kaczmarek, Marcus-Andre Deutsch, Maria-Elisabeth Rohrer, et al.
Annals of Hematology|December 17, 2008
Immunosuppressive treatment for acquired haemophilia: current practice and future directions in Germany, Austria and SwitzerlandAndreas Tiede, Angela Huth-Kühne, Johannes Oldenburg, et al.
Hamostaseologie|March 28, 2018
The role of ultralarge multimers in recombinant human von Willebrand factor - a review of physico-and biochemical studies and findings in in vivo models and in humans with von Willebrand diseasePeter L Turecek, Michael Spannagl, Thorsten Kragh, et al.
Cellular & Molecular Immunology|April 19, 2016
Arterial thrombosis in the context of HCV-associated vascular disease can be prevented by protein CPhilipp Blüm, Joachim Pircher, Monika Merkle, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Bone Marrow Research|May 27, 2014
Combination of Complement-Dependent Cytotoxicity and Relative Fluorescent Quantification of HLA Length Polymorphisms Facilitates the Detection of a Loss of HeterozygosityKlaus Witter, Roland Reibke, Marion Subklewe, et al.
Clinical Chemistry and Laboratory Medicine|May 1, 2018
External quality assessment schemes for glucose measurements in Germany: factors for successful participation, analytical performance and medical impactAndreas Bietenbeck, Wolf J Geilenkeuser, Frank Klawonn, et al.
American Journal of Clinical Pathology|January 23, 2010
Analysis of von Willebrand factor multimers by simultaneous high- and low-resolution vertical SDS-agarose gel electrophoresis and Cy5-labeled antibody high-sensitivity fluorescence detectionHelmut W Ott, Andrea Griesmacher, Mirjam Schnapka-Koepf, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|October 29, 2008
Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplantIngo Kaczmarek, Marcus-Andre Deutsch, Teresa Kauke, et al.
Expert Review of Hematology|July 4, 2025
Review of laboratory methods used for analysis of von Willebrand factor and for diagnosis of related diseasesJürgen Patzke, Nikolaus B Binder, Mariona Bono, et al.
Expert Review of Hematology|June 24, 2025
Von Willebrand factor is a multifaceted player in hemostasis requiring a diverse array of analytical and diagnostic approachesFrançois Depasse, Nikolaus B Binder, Mariona Bono, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 12, 2006
HLA-DR matching improves survival after heart transplantation: is it time to change allocation policies?Ingo Kaczmarek, Marcus-Andre Deutsch, Maria-Elisabeth Rohrer, et al.
Annals of Hematology|December 17, 2008
Immunosuppressive treatment for acquired haemophilia: current practice and future directions in Germany, Austria and SwitzerlandAndreas Tiede, Angela Huth-Kühne, Johannes Oldenburg, et al.
Hamostaseologie|March 28, 2018
The role of ultralarge multimers in recombinant human von Willebrand factor - a review of physico-and biochemical studies and findings in in vivo models and in humans with von Willebrand diseasePeter L Turecek, Michael Spannagl, Thorsten Kragh, et al.
Cellular & Molecular Immunology|April 19, 2016
Arterial thrombosis in the context of HCV-associated vascular disease can be prevented by protein CPhilipp Blüm, Joachim Pircher, Monika Merkle, et al.
Pageof 11